Britain approves Pfizer coronavirus vaccine for use, 1st in world to do so

Britain became the first country in the world to approve the Pfizer-BioNTech coronavirus vaccine candidate Wednesday, with the government announcing the shot will be rolled out across the country beginning early next week.

In a statement, a spokesperson from the Department of Health and Social Care said it had accepted the recommendation from the independent Medicines and Healthcare products Regulatory Agency for the vaccine to be used.

Read more: Canada in talks with coronavirus vaccine makers ‘every day’ as approvals near: Anand

The government said priority groups will receive the vaccine first, including care home residents, health and care staff, the elderly and the clinically extremely vulnerable. Guidance on how the vaccine will be distributed is being promised in the coming days.

Hospitals in England have been told they could receive the first doses of the Pfizer shot during the week of Dec. 7 if it receives the OK, the Guardian and Financial Times reported this week.

“It is very good news,” Health Secretary Matt Hancock told Sky News Wednesday, assuring the National Health Service “stands ready” to handle the rollout.

The U.S. Food and Drug Administration’s scientific advisers are holding a public meeting Dec. 10 to review Pfizer’s request to allow emergency use of its vaccine, and a decision could come shortly thereafter.

Canadian health officials have said Health Canada is also reviewing the vaccine and may quickly follow in the FDA’s footsteps if that agency gives the green light.

Click to play video 'Coronavirus: Vaccine delivery expected in 1st quarter of 2021, public services minister says' 1:11 Coronavirus: Vaccine delivery expected in 1st quarter of 2021, public services minister says

Coronavirus: Vaccine delivery expected in 1st quarter of 2021, public services minister says

Countries around the world have been anxiously awaiting the arrival of an effective vaccine candidate to finally combat the spread of the pandemic, which has killed nearly 1.5 million people, infected over 62 million more and wreaked havoc on the global economy.

Read more: Pfizer files for emergency use of coronavirus vaccine in U.S. — what about in Canada?

Pharmaceutical companies and researchers have raced for months to accomplish what normally takes years: develop a safe and effective vaccine to protect people from the deadly disease.

Pfizer beat other major developers in announcing results of its late-stage clinical trials in early November, which showed the vaccine had an efficacy rate over 90 per cent. The vaccine must be taken in two doses a month apart.

Click to play video 'Coronavirus: Trudeau still vague on specific date of possible COVID-19 vaccine rollout' 1:12 Coronavirus: Trudeau still vague on specific date of possible COVID-19 vaccine rollout

Coronavirus: Trudeau still vague on specific date of possible COVID-19 vaccine rollout

Pfizer said in a statement that Britain’s emergency use authorization marks “a historic moment in the fight against COVID-19.”

“This authorization is a goal we have been working toward since we first declared that science will win, and we applaud the MHRA for their ability to conduct a careful assessment and take timely action to help protect the people of the U.K.,” said CEO Albert Bourla.

“As we anticipate further authorizations and approvals, we are focused on moving with the same level of urgency to safely supply a high-quality vaccine around the world.”

More to come…

–With files from the Associated Press

© 2020 Global News, a division of Corus Entertainment Inc.

Article Source

Pinterest